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Volume 58, Number 5 Abstracts 1437Objectives: To review a single-center experience in the treatment of
ruptured abdominal aortic aneurysms (RAAAs) in a 32-year period.
Methods: A retrospective review of consecutive patients with the
diagnosis of RAAA between 1980 and 2012 was performed. Clinical vari-
ables affecting outcomes and mortality (30-day and in-hospital combined)
were analyzed.
Results: A total of 611 patients (497 males, 114 females) with
a mean age of 74 years (range, 34-100 years) were reviewed. Forty
patients (7%) died before intervention, and nine (1%) declined research
review. Of the remaining 562, endovascular aneurysm repair (EVAR)
was performed in 35 (6%) patients and open repair (OR) in 527 (94%).
The patients were analyzed by treatment period: Group G1 comprised
213 patients (38%) treated between 1980 and 1989; G2, 191 (34%)
patients treated from 1990 to 1999; and G3, 158 (28%) patients treated
between 2000 and 2012. The 30-day/in-hospital mortality was 45% in
G1, 36% in G2, and 26% in G3 (P ¼ .003; G3 vs G2 vs G1). A signiﬁcant
decrease in the mean length of stay was found in the last 10 years (G1, 25;
G2, 26; G3, 16 days; P ¼ .007). Multivariate analysis demonstrated a 1.5-
fold increase in the risk of mortality (P ¼ .002), and a 1.4-fold increase
risk of in-hospital complications for every 10 years of age (P < .008).
Increased Apache II score results in a 1.1-fold increase of mortality and
in-hospital complications (P < .0001; conﬁdence limits 1.068-1.152).
EVAR decreases the risk of mortality (P ¼ .05), but not the risk of in-
hospital complications.
Conclusions: Despite the improvement over the past decades and the
advent of EVAR, RAAA still results in a high risk of death and complica-
tions. Age and high APACHE II scores were associated with poor
outcomes. EVAR for RAAA improves mortality, but still results in signiﬁ-
cant morbidity.
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Objective: Bilateral internal carotid artery occlusions (BICAO) occlu-
sions are rare. We describe the natural history.
Methods: Retrospective review of 30,812 carotid duplex examina-
tions performed over 12 years yielded a cohort of 45 patients (pts) who
had BICAO. Data was collected till the primary end point of death or
secondary end points of stroke or myocardial infarction (MI). In those
with BICAO, multivariate analysis evaluated the association of age,
smoking, use of antiplatelets or anticoagulants, patency of external carotid
artery and vertebral arteries with the primary and secondary end-points.
Fisher exact test was used to analyze heterogeneity between survivors and
nonsurvivors. Kaplan-Meier survival analyses estimated event rates of death,
stroke, and MI.
Results: Prevalence of BICAO in this series was 0.15% with male
predominance (95%). Mean age at diagnosis was 72 611 years, and mean
follow-up was 31 months. There were no differences in comorbidities
between survivors and nonsurvivors. Freedom from death at years 1, 3,
and 5 was 76%, 64%, and 53%, and for stroke and MI, it was 89%, 87%,Fig.and 84%, and 71%, 69%, and 67%, respectively. Survival favored pts on single
antiplatelet (odds ratio [OR], 0.67; P ¼ .008) or with combination of anti-
coagulation (OR, 0.67; P ¼ .018). Although not reaching signiﬁcance, pts
who had stroke (OR, 1.07; P ¼ .653) or MI (OR, 1.25; P ¼ .190) had
poorer survival. There was no signiﬁcant association between patency of
external carotid artery or vertebral arteries (P ¼ .744) and death, stroke,
or MI.
Conclusions: A diagnosis of BICAO is associated with poor long
term survival. In this series, survival was better with use of antiplatelets or
with combination of anticoagulants.
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For patients with no adequate upper extremity peripheral venous
outﬂow, the Hemodialysis Reliable Outﬂow (HeRO) graft can provide
an opportunity for an upper extremity subcutaneous arteriovenous (AV)
dialysis graft. However, in the subset of patients who have an internal
jugular vein (IJV) catheter and contralateral central venous occlusion,
a femoral bridging catheter, which carries a high infection burden, is
required during the graft incorporation. Short of using an immediately
cannulatable AV graft sewn to a HeRO coupling device, we present here
a novel two-stage HeRO graft implantation technique that avoids the
use of a femoral bridging catheter in this subset of patients. The ﬁrst stage
of this technique is to implant the ePTFE component (EC). The EC is
tunneled subcutaneously in the upper arm ipsilateral to a concurrent IJV
catheter in a gentle curve or loop, from the arterial anastomosis incision
site to the connector incision site in the deltoid area. Then, instead of anas-
tomosing to the target artery, the proximal arterial end of the EC is folded
over and placed in the subcutaneous tissue. The preexisting IJV catheter is
maintained to provide continuous dialysis access. The second stage of the
operation is initiated in 3 to 4 weeks by reopening the arterial incision site
with dissection to free the target artery. The connector incision site is also
reopened to dissect this end free. Next, the EC arterial end within the
subcutaneous tissue is unfolded, thrombectomized, irrigated, and anasto-
mosed to the freed target artery. The chest wall catheter is then freed up
from its exit site, and the jugular entrance site is opened. After clamping
the catheter at the entrance site, it is transected, and the external part is
cleared from the ﬁeld. A stiff wire is then placed through the remaining
part of the catheter and the residual catheter is removed. In the following
step, the venous outﬂow component, which is tunneled from the IJV site
to the EC connector site, is placed through the peel-away sheath until its
tip is located at the cavo-atrial junction. Finally, the distal portion of the
venous outﬂow component is attached to the ePTFE graft in the standard
fashion, completing the HeRO graft implantation in two stages without
using a femoral bridging catheter.
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Objectives: The coexistence of symptomatic abdominal aortic aneu-
rysm (AAA) and coronary artery disease (CAD) is not uncommon. In
most cases, coronary revascularization with angioplasty or bypass (CABG)
is performed before AAA repair to reduce the risk of cardiac morbidity.
The purpose of this was to review the management of patients with symp-
tomatic large AAA and coronary artery disease.
Methods: A retrospective chart review of two patients with symptom-
atic coronary artery disease and >9 cm AAA managed using a combined
approach.
Results: A 60-year-old man presented with a 9.2 centimeter AAA
and severe CAD and a 73-year-old man with a 9.0-centimeter AAA.
Both patients underwent combined CABG and open AAA repair. Opera-
tive times were 400 and 373 minutes, respectively. Neither experienced
any postoperative complications, such as renal failure, respiratory failure,
bleeding, or infection, despite a number of medical comorbidities and
decades of tobacco use. Both men are alive and well at 8 and 9 years
respectively.
Conclusions: In special circumstances, patients with large AAA and
severe CAD can be considered for combined repair. We report two such
cases treated successfully with excellent long-term results.
